Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
1.
J Steroid Biochem Mol Biol ; 213: 105954, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34298098

RESUMO

BACKGROUND: The present study was conducted to investigate the therapeutic effects of a potent polyphenol, fisetin, on the letrozole-induced rat model of polycystic ovary syndrome (PCOS). METHODOLOGY: Twenty-four female Wistar rats (42 days old) were divided into four groups: control group (received carboxy methylcellulose (CMC 0.5 %)), PCOS group treated with letrozole (1 mg/kg), fisetin group received same dose of letrozole + fisetin (10 mg/kg), and metformin group received same dose of letrozole + metformin (300 mg/kg). At the end of the experiment, biochemical (glucose, lipid profile) and hormonal (insulin, testosterone, estradiol, and progesterone) parameters were analyzed. Histological examinations of ovaries were also conducted by hematoxylin and eosin (H&E) staining. Real-time polymerase chain reaction (PCR) and western blotting were carried out for cytochrome P450 17A1 (CYP17A1), sirtuin-1 (SIRT1), and 5' AMP-activated protein kinase (AMPK) gene expression in the ovaries. Furthermore, enzymatic activities of antioxidants including catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) in the ovaries were analyzed by colorimetric method. RESULTS: Letrozole administration resulted in a remarkable abnormality in biochemical and hormonal parameters. Fisetin normalized levels of glucose, lipid profile, homeostatic model assessment for insulin resistance (HOMA-IR), testosterone, estradiol, and progesterone. Moreover, fisetin increased expression levels of SIRT1 and AMPK, and decreased expression level of CYP17A1 in the ovaries. Additionally, fisetin showed protective effect by enhancing antioxidant activities of CAT, SOD, and GPx depleted secondary to induction of PCOS. Fisetin effects were comparable to metformin, as the standard drug used for treatment of PCOS. CONCLUSION: Our results showed that, fisetin treatment caused significant alleviating effects by restoring PCOS-induced alterations in the key genes involved in energy homeostasis and antioxidant enzymes, suggesting that it may have a key role in combating with PCOS.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Flavonóis/farmacologia , Letrozol/antagonistas & inibidores , Ovário/efeitos dos fármacos , Síndrome do Ovário Policístico/tratamento farmacológico , Proteínas Quinases Ativadas por AMP/sangue , Proteínas Quinases Ativadas por AMP/genética , Animais , Glicemia/metabolismo , Carboximetilcelulose Sódica/administração & dosagem , Catalase/sangue , Catalase/genética , Modelos Animais de Doenças , Estradiol/sangue , Feminino , Expressão Gênica , Glutationa Peroxidase/sangue , Glutationa Peroxidase/genética , Humanos , Insulina/sangue , Letrozol/toxicidade , Metformina/farmacologia , Ovário/metabolismo , Ovário/patologia , Síndrome do Ovário Policístico/sangue , Síndrome do Ovário Policístico/induzido quimicamente , Síndrome do Ovário Policístico/patologia , Progesterona/sangue , Ratos , Ratos Wistar , Sirtuína 1/sangue , Sirtuína 1/genética , Esteroide 17-alfa-Hidroxilase/antagonistas & inibidores , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/genética , Superóxido Dismutase/sangue , Superóxido Dismutase/genética , Testosterona/sangue
2.
J Clin Endocrinol Metab ; 105(12)2020 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-32865200

RESUMO

CONTEXT: Girls with premature adrenarche (PA) may have a higher risk of developing polycystic ovary syndrome (PCOS) and metabolic syndrome. The biological purpose of adrenarche is unknown and the role of novel biosynthetic pathways remains unclear. OBJECTIVE: To compare the urinary steroid metabolome and enzyme activities of girls with PA to age-matched control girls and to published steroid values of girls with normal adrenarche and of women with PCOS and their newborn daughters. DESIGN: Prospective observational study from 2009 to 2014. SETTING: Academic pediatric endocrinology referral center. PARTICIPANTS: Twenty-three girls with PA and 22 healthy, age-matched girls. MAIN OUTCOME MEASURES: Steroid metabolites in 24-hour urine samples, including 4 progesterones, 5 corticosterones, aldosterone, 13 androgens, 2 estrogens, 14 glucocorticoids, and enzyme activities represented by metabolite ratios. RESULTS: Girls with PA had a higher body mass index (mean standard deviation scores 0.9 vs -0.3, P = 0.013). Androgen excretion was higher in PA girls than in control girls (median 3257 nmol/24 hours vs 1627 nmol/24 hours, P < 0.001), in particular metabolites from alternate androgen pathways. The amount of progesterone, corticosterone, aldosterone, estrogen, and cortisol metabolites were similar between groups. Activities of 17ß-hydroxysteroid-dehydrogenase and of 17,20-lyase were higher in girls with PA. Activities of 3ß-hydroxysteroid-dehydrogenase, 21-hydroxylase, and 5α-reductase activity were not different between groups, in contrast to published results on girls with normal adrenarche or PCOS females. CONCLUSIONS: Metabolites and enzymes involved in alternate androgen pathways appear to be markers of PA. Prospective studies should assess whether steroid production in PA also differs from adrenarche at normal timing and persists into adulthood.


Assuntos
17-Hidroxiesteroide Desidrogenases/sangue , Adrenarca/sangue , Puberdade Precoce/sangue , Esteroide 17-alfa-Hidroxilase/sangue , 17-Hidroxiesteroide Desidrogenases/metabolismo , Adrenarca/metabolismo , Adrenarca/fisiologia , Androgênios/sangue , Androgênios/metabolismo , Estudos de Casos e Controles , Criança , Pré-Escolar , Corticosterona/sangue , Corticosterona/metabolismo , Estrogênios/sangue , Estrogênios/metabolismo , Feminino , Humanos , Hidrocortisona/sangue , Hidrocortisona/metabolismo , Metaboloma , Puberdade Precoce/metabolismo , Esteroide 17-alfa-Hidroxilase/metabolismo , Suíça , Regulação para Cima
3.
J Clin Endocrinol Metab ; 105(10)2020 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-32750115

RESUMO

CONTEXT: The levels of adrenal androgens are increased through the action of steroidogenic enzymes with morphological changes in the adrenal zona reticularis. OBJECTIVE: We investigated longitudinal changes in androgen levels and steroidogenic enzyme activities during early childhood. DESIGN AND PARTICIPANTS: From a prospective children's cohort, the Environment and Development of Children cohort, 114 boys and 86 girls with available blood samples from ages 2, 4, and 6 years were included. OUTCOME MEASUREMENTS: Serum concentrations of adrenal androgens using liquid chromatography-tandem mass spectrometry and steroidogenic enzyme activity calculated by the precursor/product ratio. RESULTS: During ages 2 to 4 years, 17,20-lyase and dehydroepiandrosterone (DHEA) sulfotransferase activities increased (P < 0.01 for both in boys). During ages 4 to 6 years, 17,20-lyase activity persistently increased, but 3ß-hydroxysteroid dehydrogenase (HSD) and 17ß-HSD activities decreased (P < 0.01 for all). Serum DHEA sulfate (DHEA-S) levels persistently increased from 2, 4, to 6 years, and DHEA, 17-hydroxyprogesterone, and androstenedione levels increased during ages 4 to 6 years (P < 0.01 for all). Serum DHEA-S levels during early childhood were associated with body mass index z-scores (P = 0.001 in only boys). CONCLUSION: This study supports in vivo human evidence of increased 17,20-lyase and DHEA sulfotransferase activities and decreased 3ß-HSD activity during early childhood.


Assuntos
3-Hidroxiesteroide Desidrogenases/sangue , Adrenarca/sangue , Androgênios/sangue , Esteroide 17-alfa-Hidroxilase/sangue , Sulfotransferases/sangue , 17-Hidroxiesteroide Desidrogenases/sangue , 17-Hidroxiesteroide Desidrogenases/metabolismo , 17-alfa-Hidroxiprogesterona/sangue , 17-alfa-Hidroxiprogesterona/metabolismo , 3-Hidroxiesteroide Desidrogenases/metabolismo , Adrenarca/metabolismo , Androgênios/metabolismo , Androstenodiona/sangue , Androstenodiona/metabolismo , Criança , Pré-Escolar , Sulfato de Desidroepiandrosterona/sangue , Sulfato de Desidroepiandrosterona/metabolismo , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Masculino , Estudos Prospectivos , Esteroide 17-alfa-Hidroxilase/metabolismo , Sulfotransferases/metabolismo , Zona Reticular/metabolismo
4.
BMJ Case Rep ; 20172017 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-28487303

RESUMO

Development of gonadal and phenotypic sex during embryogenesis invariably corresponds to the genotypic sex. However, some disorders of sex development are associated with discordance between the chromosomal, gonadal or phenotypic sex which include complete androgen insensitivity syndrome, 46XY complete gonadal dysgenesis (Swyer syndrome) and, rarely, congenital adrenal hyperplasia due to CYP 17A1 (17α-hydroxylase) deficiency. The enzyme CYP17A1 includes 17α-hydroxylase and 17,20-lyase which are required for the synthesis of cortisol and sex steroids, respectively. The consequent cortisol deficiency results in a compensatory increase in adrenocorticotropic hormone (ACTH) drive, which stimulates the production of deoxycorticosterone and corticosterone leading to hypertension and hypokalaemia. Concurrent lack of sex steroids results in sexual infantilism without ambiguity. Both the genotypic males and females present during adolescence with a female phenotype, sexual infantilism and hypertension depending on the severity of the enzyme deficiency. We describe a case of CYP17A1 deficiency in a phenotypic female with 46XY karyotype who presented with sexual infantilism but without hypertension.


Assuntos
Hiperplasia Suprarrenal Congênita/diagnóstico , Cariótipo , Fenótipo , Esteroide 17-alfa-Hidroxilase/sangue , Adolescente , Hiperplasia Suprarrenal Congênita/sangue , Feminino , Humanos
5.
Sci Rep ; 6: 29468, 2016 07 12.
Artigo em Inglês | MEDLINE | ID: mdl-27406023

RESUMO

Cytochrome P450 17A1 (CYP17A1) is an important target in the treatment of prostate cancer because it produces androgens required for tumour growth. The FDA has approved only one CYP17A1 inhibitor, abiraterone, which contains a steroidal scaffold similar to the endogenous CYP17A1 substrates. Abiraterone is structurally similar to the substrates of other cytochrome P450 enzymes involved in steroidogenesis, and interference can pose a liability in terms of side effects. Using non-steroidal scaffolds is expected to enable the design of compounds that interact more selectively with CYP17A1. Therefore, we combined a structure-based virtual screening approach with density functional theory (DFT) calculations to suggest non-steroidal compounds selective for CYP17A1. In vitro assays demonstrated that two such compounds selectively inhibited CYP17A1 17α-hydroxylase and 17,20-lyase activities with IC50 values in the nanomolar range, without affinity for the major drug-metabolizing CYP2D6 and CYP3A4 enzymes and CYP21A2, with the latter result confirmed in human H295R cells.


Assuntos
Desenho de Fármacos , Neoplasias da Próstata/sangue , Neoplasias da Próstata/tratamento farmacológico , Esteroide 17-alfa-Hidroxilase/antagonistas & inibidores , Androstenos/farmacologia , Domínio Catalítico , Linhagem Celular Tumoral , Sobrevivência Celular , Cromatografia Líquida , Cristalografia por Raios X , Humanos , Concentração Inibidora 50 , Ligantes , Masculino , Espectrometria de Massas , Simulação de Acoplamento Molecular , Nitrogênio/química , Próstata/metabolismo , Ligação Proteica , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/metabolismo , Esteroides
6.
Br J Cancer ; 112(10): 1717-24, 2015 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-25897673

RESUMO

BACKGROUND: This study aimed to investigate copy number variations (CNVs) of CYP17A1 and androgen receptor (AR) genes in serum cell-free DNA collected before starting abiraterone in 53 consecutive patients with castration-resistant prostate cancer (CRPC). METHODS: Serum DNA was isolated and CNVs were analysed for AR and CYP17A1 genes using Taqman copy number assays. The association between CNVs and progression-free/overall survival (PFS/OS) was evaluated by the Kaplan-Meier method and log-rank test. RESULTS: Median PFS of patients with AR gene gain was 2.8 vs 9.5 months of non-gained cases (P < 0.0001). Patients with CYP17A1 gene gain had a median PFS of 2.8 months vs 9.2 months in the non-gained patients (P = 0.0014). A lower OS was reported in both cases (AR: P < 0.0001; CYP17A1: P = 0.0085). Multivariate analysis revealed that PSA decline ⩾ 50%, AR and CYP17A1 CNVs were associated with shorter PFS (P < 0.0001, P = 0.0004 and P = 0.0450, respectively), while performance status, PSA decline ⩾ 50%, AR CNV and DNA concentration were associated with OS (P = 0.0021, P = 0.0014, P = 0.0026 and P = 0.0129, respectively). CONCLUSIONS: CNVs of AR and CYP17A1 genes would appear to be associated with outcome of CRPC patients treated with abiraterone.


Assuntos
Androstenos/uso terapêutico , Variações do Número de Cópias de DNA , Neoplasias de Próstata Resistentes à Castração/tratamento farmacológico , Neoplasias de Próstata Resistentes à Castração/genética , Receptores Androgênicos/sangue , Esteroide 17-alfa-Hidroxilase/sangue , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , DNA/genética , Intervalo Livre de Doença , Humanos , Calicreínas/sangue , Masculino , Pessoa de Meia-Idade , Antígeno Prostático Específico/sangue , Neoplasias de Próstata Resistentes à Castração/sangue , Neoplasias de Próstata Resistentes à Castração/enzimologia , Receptores Androgênicos/genética , Estudos Retrospectivos , Esteroide 17-alfa-Hidroxilase/genética
7.
Clin Endocrinol (Oxf) ; 82(5): 639-47, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25347939

RESUMO

OBJECTIVES: To investigate the long-term outcome after unilateral adrenalectomy in patients with primary aldosteronism (PA) and to establish the role of functional pathology for the final diagnosis of aldosterone-producing adenoma (APA) or hyperplasia. DESIGN: A single-centre, retrospective cohort study in a hospital setting. PATIENTS: Consecutive patients with PA, n = 120, who underwent unilateral adrenalectomy between 1985 and 2010. Preoperative and postoperative data were analysed. To indicate the site of aldosterone secretion in the resected adrenal, we added functional methods to routine histopathology, using in situ hybridization and immunohistochemistry to detect the presence of enzymes needed for aldosterone (CYP11B2) and cortisol (CYP11B1, CYP17A1) synthesis. RESULTS: The median follow-up was 5 years and the cure rate of PA 91%. Hypertension was improved in 97% and normalized in 38%. Functional histopathology changed the final diagnosis from APA to hyperplasia in 6 cases (7%). Five of these had no expression of or staining for aldosterone synthase in the adenoma, but only in nodules in the adjacent cortex. All except one APA patient were cured of PA. They had lower preoperative serum potassium and higher 24-h urinary aldosterone than patients with hyperplasia. Among patients with hyperplasia 16 of 26 were cured. CONCLUSIONS: Most patients were cured of PA by unilateral adrenalectomy. Almost all noncured benefitted from the operation as the blood pressure improved. Functional histopathology proved helpful in the distinction between APA and hyperplasia, and we recommend that functional histopathology should be added to routine histopathology to improve the diagnostic evaluation and aid in tailoring the follow-up.


Assuntos
Adenoma/metabolismo , Adrenalectomia , Hiperaldosteronismo/complicações , Hiperplasia/metabolismo , Adenoma/cirurgia , Adolescente , Neoplasias das Glândulas Suprarrenais/metabolismo , Neoplasias das Glândulas Suprarrenais/cirurgia , Adulto , Idoso , Aldosterona/química , Citocromo P-450 CYP11B2/sangue , Feminino , Seguimentos , Hospitais , Humanos , Hidrocortisona/química , Hipertensão/complicações , Imuno-Histoquímica , Hibridização In Situ , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Esteroide 11-beta-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/sangue , Adulto Jovem
8.
J Pediatr ; 165(2): 280-4, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24862381

RESUMO

OBJECTIVE: To characterize the urinary steroid metabolome of neonates and infants born either at term or preterm. STUDY DESIGN: We retrospectively analyzed urinary steroid hormone metabolites determined by gas chromatography-mass spectrometry of 78 neonates and infants born at term and 83 neonates and infants born preterm (median 34 weeks of gestational age). The subjects' 11ß-hydroxylase and 21-hydroxylase activities were assessed on the basis of urinary metabolite substrate-to-product ratios. RESULTS: Preterm neonates and infants had elevated urinary concentrations of 17α-hydroxyprogesterone (17OHP) metabolites (P<.001) but lower urinary concentrations of the 21-deoxycortisol metabolite pregnanetriolone (PTO) (P<.01). One reason was lower 11ß-hydroxylase activity in preterms. We could demonstrate a correlation between low 11ß-hydroxylase activity and high urinary concentrations of 17OHP metabolites (r=0.51, P<.001) but low urinary concentrations of the 21-deoxycortisol metabolite PTO (r=-0.24, P=.03) in preterms. CONCLUSIONS: Low 11ß-hydroxylase activity may explain increased 17OHP but decreased 21-deoxycortisol metabolite excretion in preterms. Our analysis clarifies, first, why preterms have higher 17OHP levels and thus higher rates of false-positive screening results for congenital adrenal hyperplasia than do term infants, and, second, why 21-deoxycortisol or its urinary metabolite PTO is more specific than 17OHP for the diagnosis of 21-hydroxylase deficiency.


Assuntos
17-alfa-Hidroxiprogesterona/urina , Hiperplasia Suprarrenal Congênita/enzimologia , Hiperplasia Suprarrenal Congênita/urina , Recém-Nascido Prematuro , Esteroide 11-beta-Hidroxilase/sangue , Cromatografia Gasosa , Cortodoxona/urina , Feminino , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Lactente , Recém-Nascido , Masculino , Espectrometria de Massas , Metaboloma , Pregnanotriol/análogos & derivados , Pregnanotriol/urina , Estudos Retrospectivos , Esteroide 17-alfa-Hidroxilase/sangue
9.
N Z Med J ; 125(1355): 71-4, 2012 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-22722218

RESUMO

An 18-year-old woman with primary amenorrhoea and pubertal delay was investigated for mild labile hypertension and secondary hypogonadism. Low renin and normal aldosterone levels combined with evidence of primary adrenal insufficiency suggested partial 17-alpha hydroxylase enzyme deficiency. The diagnosis was confirmed by measurement of 24-hour urine steroid metabolites and whole gene sequencing of CYP17A1 that demonstrated c.160_162delTTC (p.Phe54del) homozygous mutation. Ultrasound showed bilateral small ovaries with multiple cysts. The serum anti-mullerian hormone concentration was unremarkable at 6.6 (normal <12.6 ng/ml) but the outlook for her future ovulatory potential is uncertain. Dexamethasone 0.25 mg pre-bed and hydrocortisone 5 mg on waking normalised her hormonal profile and her blood pressure without side-effects.


Assuntos
Hiperplasia Suprarrenal Congênita/enzimologia , Puberdade Tardia/enzimologia , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide Hidroxilases/deficiência , Adolescente , Hiperplasia Suprarrenal Congênita/genética , Biomarcadores/sangue , Feminino , Glucocorticoides/uso terapêutico , Humanos , Mutação
10.
Sci Total Environ ; 414: 81-9, 2012 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-22119029

RESUMO

BACKGROUND: Reliable techniques to measure polychlorinated biphenyl (PCB) congeners make the clearer definition of their effects on human health possible. Given that PCBs are classified as endocrine disrupters, we sought to explore the expression of some key genes involved in sex steroid metabolism. OBJECTIVES: To examine common classification schemes of PCB congeners and determine whether exposure to groups classified by mechanism of action alter the gene expression (GE) of CYP17, CYP19, and ESR1 and ESR2. METHODS: GE and exposure to various classifications of lipid-adjusted PCB congeners were examined in 139 daughters of the Michigan Fisheaters' Cohort. Using mixed models analyses and adjusting for age, menopausal status, and current use of oral contraceptives and hormone replacement therapy, GE data were regressed on exposure to PCB congener groupings based on mechanism of action. RESULTS: Three novel findings are elucidated: first, that up-regulation of CYP19 expression is associated with exposure to PCB groupings containing dioxin-like, potentially anti-estrogenic, immunotoxic congeners, including PCB IUPAC #74, #105, #118, #138, #156, #157, #158, #167, and #170 from this cohort. Second, that exposure to similar congeners (PCB IUPAC #105, #156, #157, #158, and #167 in this cohort) but using a classification based solely on hormonal mechanisms of action is associated with increased expression of ESR2. Third, that increased expression of CYP17 is of borderline significance when associated with exposure to PCB IUPAC #118, #138, and #156. CONCLUSIONS: These findings are both counter-intuitive and intriguing. Rather than exhibiting anti-estrogenic effects alone, they suggest that these congeners up-regulate the major enzyme involved in estrogen synthesis and tend to confirm previous findings of links between AhR and ER signaling pathways. Replication of these findings, expansion of the number of genes examined, exploration of mixtures of environmental chemicals, and subsequent study of health outcomes in a larger cohort are future priorities.


Assuntos
Disruptores Endócrinos/toxicidade , Regulação da Expressão Gênica/efeitos dos fármacos , Bifenilos Policlorados/classificação , Bifenilos Policlorados/toxicidade , Aromatase/sangue , Disruptores Endócrinos/química , Receptor alfa de Estrogênio/sangue , Receptor beta de Estrogênio/sangue , Feminino , Humanos , Michigan , Modelos Estatísticos , Análise Multivariada , Bifenilos Policlorados/química , RNA Polimerase II/metabolismo , RNA Ribossômico 18S/metabolismo , Esteroide 17-alfa-Hidroxilase/sangue
11.
Mol Vis ; 17: 2297-310, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21921981

RESUMO

PURPOSE: To evaluate the relationship among single nucleotide polymorphisms (SNPs) in steroidogenesis enzyme genes, serum levels of sex steroids, and high myopia in Taiwanese male and female populations. METHODS: A campus-based sample of 283 cases (145 males and 138 females) with high myopia and 280 controls (144 males and 136 females) with low myopia or emmetropia was studied. Estradiol, progesterone, and testosterone levels were determined using enzyme-linked immunosorbent assay kits. We genotyped six SNPs within five steroidogenesis enzyme genes (17 alpha-hydroxylase/17,20 lyase [CYP17A1], 3 beta-hydroxysteroid dehydrogenase [HSD3B1], 17 beta-hydroxysteroid dehydrogenase 1 [HSD17B1], steroid-5-alpha-reductase, alpha polypeptide 2 [SRD5A2], and aromatase [CYP19A1]) using polymerase chain reaction-restriction fragment length polymorphism methods. Student's t-tests, χ(2) tests, logistic regression, multifactor dimensionality reduction (MDR) methods, and ANOVA were used to determine significance. RESULTS: An MDR analysis corroborated the synergistic genotype association and demonstrated that synergistic interaction between rs6203 (HSD3B1), rs10046 (CYP19A1), and sex might confer susceptibility to high myopia (p=0.019). In both male and female subjects, levels of testosterone were significantly higher in cases than in controls; in male subjects, the levels of estradiol were significantly higher and those of progesterone were significantly lower in cases (all p-values <0.001). The rs605059 (HSD17B1), with sex-gene interaction, showed association with estradiol levels in males (p=0.035) and testosterone levels in females (p=0.027). CONCLUSIONS: Testosterone levels correlate with high myopia, and interaction of steroidogenesis enzyme genes and sex may be a modulating factor in sex hormone metabolism and high-myopia risk.


Assuntos
Povo Asiático , Estradiol/genética , Miopia/genética , Esteroides/sangue , Testosterona/genética , 17-Hidroxiesteroide Desidrogenases/sangue , 17-Hidroxiesteroide Desidrogenases/genética , 3-Hidroxiesteroide Desidrogenases/sangue , 3-Hidroxiesteroide Desidrogenases/genética , Adulto , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Estradiol/sangue , Estradiol Desidrogenases/sangue , Estradiol Desidrogenases/genética , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Miopia/sangue , Miopia/epidemiologia , Polimorfismo de Nucleotídeo Único , Fatores Sexuais , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/genética , Taiwan/epidemiologia , Testosterona/sangue
12.
Steroids ; 76(12): 1351-7, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21787799

RESUMO

BACKGROUND: Epilepsy in women may be associated with reproductive disorders and alterations in serum steroid levels. Some steroids can be induced by epilepsy and/or treatment with antiepileptic drugs; however, there are still limited data available concerning this effect on the levels of other neuroactive steroid metabolites such as 3a-hydroxy-5a/b-reduced androstanes. AIM: To evaluate steroid alterations in women with epilepsy (WWE) on lamotrigine monotherapy. SUBJECTS AND METHODS: Eleven WWE and 11 age-matched healthy women underwent blood sampling in both phases of their menstrual cycles (MCs). The steroid metabolome, which included 30 unconjugated steroids, 17 steroid polar conjugates, gonadotropins, and sex hormone-binding globulin (SHBG), was measured using gas chromatography-mass spectrometry (GC-MS) and radioimmunoassay (RIA). RESULTS: WWE had lower cortisol levels (status p<0.001), but elevated levels of unconjugated 17-hydroxypregnenolone (status p<0.001). Progesterone was higher in the follicular menstrual phase (FP) in WWE than in the controls (status×menstrual phase p<0.05, Bonferroni multiple comparisons p<0.05), whereas 17-hydroxyprogesterone was higher in WWE in both menstrual phases (status p<0.001). The steroid conjugates were mostly elevated in WWE. The levels of 5α/ß-reduced androstanes in WWE that were significantly higher than the controls were etiocholanolone (status p<0.001), 5α-androstane-3α,17ß-diol (status p<0.001), and the 5α/ß-reduced androstane polar conjugates (status p<0.001). CONCLUSIONS: WWE showed a trend toward higher circulating 3α-hydroxy-5α/ß-reduced androstanes, increased activity of 17α-hydroxylase/17,20 lyase in the Δ(5)-steroid metabolic pathway, and increased levels of the steroid polar conjugates.


Assuntos
17-alfa-Hidroxipregnenolona/sangue , Androstanos/sangue , Androstanos/metabolismo , Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Epilepsia/metabolismo , Triazinas/uso terapêutico , Adulto , Androstanóis/sangue , Anticonvulsivantes/efeitos adversos , Feminino , Humanos , Lamotrigina , Metaboloma , Esteroide 17-alfa-Hidroxilase/sangue , Triazinas/efeitos adversos
13.
Urology ; 78(4): 902-7, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21676446

RESUMO

OBJECTIVE: To investigate the association of CYP17 polymorphism with 17ß-estradiol (E2) and testosterone (T) concentration in hypospadias. METHODS: Two-hundred twenty-three boys (91 with hypospadias and 132 age-matched controls) were included in the study. CYP17 polymorphism was evaluated using the polymerase chain reaction-restriction fragment length polymorphism method, whereas T and E2 levels were estimated in serum by enzyme-linked immunosorbent assay. Association between CYP17 genotypes and 17ß-E2, T, and their ratio (E2/T) was analyzed by analysis of variance followed by Tukey's test. 17ß-E2, T, and E2/T ratio was also compared among the different degrees of hypospadias, as well as in controls, by unpaired Student's t-test. RESULTS: Significantly low levels of T were observed in severe-degree hypospadias (n = 14; mean ± SD = 1.01 ± 0.57) compared with mild cases (n = 77; mean ± SD = 1.93 ± 1.40) and controls (mean ± SD = 3.32 ± 2.06) (P <.05). E2/T ratio was also significantly higher in hypospadias cases (5.36 ± 3.55) compared with controls (2.21 ± 2.52). Heterozygous variants (A1/A2) of CYP17 were present in higher frequency (OR = 0.96; 95% CI = .518-1.770) and homozygous (A2) variants were less frequently found in hypospadias (OR = 0.87; 95% CI = .363-2.077), but results were insignificant. No association between 17ß-E2 and T with different CYP17 genotypes was observed. CONCLUSION: Our study suggests that, although polymorphism in CYP17 gene may not be associated with 17ß-E2 and T concentrations in hypospadias cases, low levels of T and higher E2/T ratio might possibly act as risk factors for hypospadias.


Assuntos
Estradiol/sangue , Hipospadia/sangue , Hipospadia/genética , Polimorfismo Genético , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/genética , Testosterona/sangue , Estudos de Casos e Controles , Criança , Pré-Escolar , Genótipo , Homozigoto , Humanos , Lactente , Masculino , Polimorfismo de Fragmento de Restrição
14.
Prostate ; 69(9): 928-37, 2009 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-19267349

RESUMO

BACKGROUND: CYP17A1 is currently a target for total androgen blockade in advanced prostate cancer (CaP) patients. After castration, or removal of testicular androgens, CYP17A1 can act as a rate-limiting enzyme in androgen synthesis from cholesterol or other adrenal precursors within the tumor microenvironment ultimately contributing to disease progression. Herein we provide evidence that CYP17A1 could also be a mediator of cell-to-cell communication within the CaP tumor microenvironment. METHODS: CYP17A1 expression was evaluated by immunohistochemical analysis of human tumor sections and Western blot analysis of CaP patients' serum and exosome isolates. CYP17A1 activity assays were conducted in human serum (and positive control human liver and kidney microsomes) using progesterone as a precursor and an LC-MS endpoint. RESULTS: These studies revealed that the expression pattern of CYP17A1 is typical of a secretory protein as it is localized to the luminal pole of the cells in exocrine secretory mode. CYP17A1 is expressed in human serum and in fact is elevated in the serum of CaP patients as compared to healthy controls. Serum CYP17A1 activity could not be confirmed, however, verification of CYP17A1 expression in exosomes suggests a role in cell-to-cell communication within the tumor microenvironment. CONCLUSIONS: CYP17A1 is a crucial enzyme for de novo androgen synthesis within the tumor microenvironment after removal of testicular androgens by castration. We provide evidence for a novel role for CYP17A1 in serum and further reiterate the importance of targeting this enzyme in CaP progression.


Assuntos
Androgênios/biossíntese , Orquiectomia , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/cirurgia , Esteroide 17-alfa-Hidroxilase/sangue , Neoplasias do Córtex Suprarrenal , Comunicação Celular/fisiologia , Linhagem Celular Tumoral , Polaridade Celular/fisiologia , Colesterol/metabolismo , Progressão da Doença , Ativação Enzimática/fisiologia , Exossomos/enzimologia , Humanos , Rim/enzimologia , Masculino , Microssomos Hepáticos/enzimologia , NADPH-Ferri-Hemoproteína Redutase/metabolismo , Neoplasias da Próstata/patologia , Esteroide 17-alfa-Hidroxilase/metabolismo
15.
Nat Clin Pract Urol ; 5(11): 610-20, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18985049

RESUMO

Androgen receptor (AR) signaling has a key role in the pathogenesis of prostate cancer. AR gene amplification, AR overexpression, and activating mutations in the AR occur more frequently as castration-resistant prostate cancer (CRPC) evolves, with intratumoral androgen levels remaining sufficient for AR activation despite castration. The source of these androgens might be either adrenal or intratumoral. AR signaling, therefore, remains a valid treatment target for patients with CRPC. CYP17 is a key enzyme for androgen biosynthesis. The imidazole antifungal agent ketoconazole weakly and nonspecifically inhibits CYP17, but remains unlicensed for this indication. Chemists at the Cancer Research UK Centre for Cancer Therapeutics have designed a novel, selective, irreversible inhibitor of CYP17 called abiraterone, which is more than 20 times more potent than ketoconazole. Abiraterone acetate, a prodrug, has undergone phase I assessment, and is rapidly progressing from phase II to phase III trials, in view of its high level of antitumor activity. This agent is safe and well tolerated, and activity profiles suggest that approximately 50% of CRPC remains AR-ligand driven. Other CYP17 inhibitors with alternative mechanisms of action, for example VN/124-1, are in preclinical development. The rationale for and implications of CYP17 inhibition and the CYP17-targeting agents in development are discussed in this Review.


Assuntos
Antineoplásicos Hormonais/uso terapêutico , Neoplasias da Próstata/tratamento farmacológico , Esteroide 17-alfa-Hidroxilase/antagonistas & inibidores , Animais , Antineoplásicos Hormonais/farmacologia , Humanos , Masculino , Neoplasias da Próstata/sangue , Neoplasias da Próstata/patologia , Esteroide 17-alfa-Hidroxilase/sangue
16.
Beijing Da Xue Xue Bao Yi Xue Ban ; 40(2): 221-2, 2008 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-18458702

RESUMO

A 16-year-old "female" patient presented as hypertension, hypokalemia, male pseudohermaphroditism, lowered gonadal steroids and cortisol, elevated adrenocorticotropic hormone and pituitary gonadotropin, and 46 XY karyotype. The patient was diagnosed as 17 alpha-hydroxylase deficiency, a rare case of congenital adrenal hyperplasia. "She" chose to remain female appearance and social gender after negotiation with the parents. Cryptor-chidism of both inguinal canals was surgically removed for preventing canceration. After the surgery, a very small daily dose of dexamethasone (0.187 5 mg at bedtime) was enough to control hypertension and hypokalemia, and the therapy of conjugated estrogens (Premarin) was given to promote the development of female characters. After 6 months of treatment, normotension and normokalemia remained, and pubarche and mammogenesis emerged.


Assuntos
Hiperplasia Suprarrenal Congênita/diagnóstico , Dexametasona/uso terapêutico , Esteroide 17-alfa-Hidroxilase/sangue , Adolescente , Hiperplasia Suprarrenal Congênita/tratamento farmacológico , Hiperplasia Suprarrenal Congênita/metabolismo , Humanos , Masculino
18.
Eur J Obstet Gynecol Reprod Biol ; 127(1): 99-105, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16460870

RESUMO

BACKGROUND: The study aim was to investigate the relationship between insulin resistance (IR), beta-cell function (betaF), hyperandrogenism and proinsulin levels during an oral glucose tolerance test (OGTT) in women with polycystic ovary syndrome (PCOS). METHODS: One hundred and twenty-six selected women were classified as follows: PCOS, BMI > 25 kg/m2 (n = 39); PCOS, BMI < 25 kg/m2 (n = 54); controls, BMI > 25 kg/m2 (n = 14); controls, BMI < 25 kg/m2 (n = 19). Blood samples were collected between the third and sixth day of a spontaneous menstrual cycle, at 9:00 a.m., after an overnight fast. Serum levels of FSH, LH, PRL, 17alpha-OH-progesterone, SHBG, testosterone, delta4-androstenedione, insulin, proinsulin and glucose were measured. A 75 g OGTT was performed, and concentrations of glucose, insulin and proinsulin were also measured at t = 30, 60, 90, and 120 min. RESULTS: The markers of insulin secretion and the AUC for proinsulin were higher in obese and overweight women and in women with PCOS, respectively. The AUC for proinsulin was positively correlated with markers of IR, betaF and androgen levels. An inverse relationship between PI/I values and indices of IR and betaF was observed. CONCLUSIONS: Increased proinsulin levels reflect, most probably, insulin resistance, which is the key disorder in PCOS-associated metabolic abnormalities. Beta-cell function, pre-proinsulin mRNA processing and proinsulin conversion to insulin could be initially increased as a result of IR. An interaction between circulating proinsulin and androgen biosynthesis or action might also exist.


Assuntos
Resistência à Insulina , Células Secretoras de Insulina/metabolismo , Síndrome do Ovário Policístico/sangue , Proinsulina/sangue , Adolescente , Adulto , Análise de Variância , Androstenodiona/sangue , Área Sob a Curva , Biomarcadores/sangue , Glicemia/metabolismo , Índice de Massa Corporal , Feminino , Hormônios/sangue , Humanos , Insulina/sangue , Obesidade/sangue , Obesidade/etiologia , Sobrepeso/sangue , Sobrepeso/etiologia , Síndrome do Ovário Policístico/complicações , Síndrome do Ovário Policístico/metabolismo , Gravidez , Globulina de Ligação a Hormônio Sexual/metabolismo , Esteroide 17-alfa-Hidroxilase/sangue , Testosterona/sangue
19.
Hum Reprod ; 20(8): 2162-7, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15878919

RESUMO

BACKGROUND: CYP17, which encodes cytochrome P450c17alpha, mediates both steroid 17alpha-hydroxylase and 17,20-lyase activities, and is essential for the production of glucocorticoids and sex steroids. There is evidence that a common polymorphism in CYP17 (T27C) is associated with estrogen levels, making it a potential marker of disease risk. METHODS: This is the first study to examine the relationship between CYP17 and estradiol (E2) using serum sampled exclusively from the early follicular phase of the menstrual cycle. We assessed the relationship between CYP17 and serum hormone levels, menstrual cycle length, bleed length, and age at menarche in 164 pre-menopausal women. RESULTS: Among women with body mass index (BMI) < or =25 kg/m2, those with the TC and CC genotypes had 19 and 42% higher E2 (P for trend 0.007) and 14 and 30% higher dehydroepiandrosterone sulphate respectively (P for trend 0.10) than women with the TT genotype. Androstenedione levels did not differ between genotypes. Among women with BMI >25 kg/m2, hormone levels did not differ by genotype. Women with the C allele were also more likely to have menstrual cycle lengths <27 days [odds ratio (OR) for TC=2.36, 95% confidence interval (CI)=1.24-4.52; OR for CC=5.59, 95% CI=1.53-20.43 compared to TT]. CYP17 genotype was not associated with menstrual bleed length or age at menarche. CONCLUSION: The CYP17 T27C polymorphism may be a marker of endocrine function.


Assuntos
Marcadores Genéticos , Pré-Menopausa/sangue , Pré-Menopausa/genética , Esteroide 17-alfa-Hidroxilase/sangue , Esteroide 17-alfa-Hidroxilase/genética , Adolescente , Adulto , Índice de Massa Corporal , Feminino , Fase Folicular/sangue , Fase Folicular/genética , Genótipo , Humanos , Menarca/genética , Menstruação/sangue , Menstruação/genética , Pessoa de Meia-Idade , Valor Preditivo dos Testes
20.
Prostate Cancer Prostatic Dis ; 7(4): 333-7, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15477877

RESUMO

Polymorphism of the steroid hormone-related genes might affect life-long androgen exposure, thus altering a risk of prostate cancer incidence. To evaluate the effect of the polymorphisms of CYP17 and SRD5A2 on serum steroid hormone levels, the 164 male Japanese cohort were tested for serum hormone levels and the genotype of the polymorphisms of CYP17 (T-C base substitution in the promoter region) and SRD5A2 (V89L). The linear trends across the CYP17 genotypes in serum-free testosterone and androstenedione levels were found, suggesting the importance of the polymorphism of CYP17 in determining the circulating androgen levels.


Assuntos
3-Oxo-5-alfa-Esteroide 4-Desidrogenase/genética , Androstenodiona/sangue , Biomarcadores Tumorais/sangue , Polimorfismo Genético , Neoplasias da Próstata/genética , Esteroide 17-alfa-Hidroxilase/genética , Testosterona/sangue , 3-Oxo-5-alfa-Esteroide 4-Desidrogenase/sangue , Idoso , Idoso de 80 Anos ou mais , Androgênios/sangue , Estudos de Coortes , DNA de Neoplasias/sangue , DNA de Neoplasias/genética , Genótipo , Humanos , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/sangue , Neoplasias da Próstata/epidemiologia , Fatores de Risco , Esteroide 17-alfa-Hidroxilase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...